seed
Stage
1
Investors
About
Paterna Biosciences develops in vitro spermatogenesis (IVS) technology to generate viable sperm from stem cells for use in clinical fertility treatments, aiming to address genetic and male-factor infertility.
Explore Paterna Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.